Skip to main content
OpenTrials
Completed

NCT Number: NCT01214551

Exercise-induced Bronchoconstriction Diagnostics: Impact of a Repeated Exercise Challenge Test

The purpose of this study is to increase the knowledge of the possible diagnostic effect of exercise induced bronchoconstriction performing a repeated exercise challenge test.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–45 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinikk for allergi og luftveissykdommer

Oslo, Ullevål, 0855, Norway

About this study

Prior studies have shown that the intensity influences the sensitivity of exercise challenge tests (ECT) and that a heart rate-based protocol does not ensure sufficient exercise intensity to induce bronchoconstriction. It is not common clinical practice to perform a pre ECT to establish maximal heart rate or maximal oxygen uptake. The heart rate formula recommended by ATS (HRmax= 220-age) is usually applied to determine recommended intensity of the ECT. Conducting a second ECT, based on the knowledge of the first test, introduce the possibility to adjust the intensity on an individual basis. In addition, based on clinical experience, patients may seem reluctant to perform maximal the first time they undergo an ECT on a treadmill. The hypothesis is that patients are less reluctant to perform maximal the second time they undergo the test when they are more accustomed to the procedure and the treadmill by itself.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Referred to Klinikk for allergi og luftveissykdommer
  • Meet at least 3 out of 5 criteria (symptoms related to exercise):
  • Cough during exercise or within 5 minutes after exercise
  • Wheeze during exercise or within 5 minutes after exercise
  • Heavy breathing, expiratory in particular, during exercise or within 5 minutes after exercise (duration 5 minutes or more)
  • Improvement of physical fitness/breath is lacking despite of exercise intensification
  • Chest tightness during or after exercise
  • Patients former diagnosed with-and treated for asthma who have symptoms of EIB are included in the study.

Exclusion criteria

  • Ongoing respiratory infection or recent respiratory infection, judged by the responsible doctor to be of importance of the result
  • The inability to perform an Exercise challenge test with maximum effort

Treatment and study plan

Primary outcomes

  1. Forced expiratory volume in one second (FEV1)

    Time frame: up to 4 weeks

Secondary outcomes

  1. Forced vital capacity (FVC)

    Time frame: up to 4 weeks

  2. Forced expiratory flow at 50 % FVC(FEF50%)

    Time frame: up to 4 weeks

  3. Fractional exhaled nitric oxide (FENO)

    Time frame: up to 4 weeks

  4. Total lung capacity (TLC)

    Time frame: up to 4 weeks

  5. Specific airway resistance (sRAW)

    Time frame: up to 4 weeks

  6. Specific airway conductance (sGAW)

    Time frame: up to 4 weeks

  7. Residual volume (RV)

    Time frame: up to 4 weeks

  8. Diffusing capacity (TLCO)

    Time frame: up to 4 weeks

  9. Maximum voluntary ventilation (MVV)

    Time frame: up to 4 weeks

  10. Breathing reserve (BR)

    Time frame: up to 4 weeks

  11. Respiratory exchange ration (RER)

    Time frame: up to 4 weeks

  12. Oxygen uptake peak (VO2 peak)

    Time frame: up to 4 weeks

  13. Heart rate peak (HR peak)

    Time frame: up to 4 weeks

  14. Ventilation peak (VE peak)

    Time frame: up to 4 weeks

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Collaborators

  • Klinikk for allergi og luftveissykdommer

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Oct 5, 2010
Registry last updated
Feb 9, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.